Myocardial insulin resistance and cardiac complications of diabetes.
about
Diabetic cardiomyopathy: bench to bedsideDiabetic cardiomyopathy: signaling defects and therapeutic approachesInsulin signaling regulates mitochondrial function in pancreatic beta-cellsGLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study.Hyperinsulinemia improves ischemic LV function in insulin resistant subjects.Cardiac remodeling in obesity.Functional changes of the coronary microvasculature with aging regarding glucose tolerance, energy metabolism, and oxidative stress.Coffee consumption and mortality in women with cardiovascular diseaseAPpEaLINg therapeutic target for obesity cardiomyopathy?Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Free fatty acid oxidation in insulin resistance and obesity.Myocardial insulin action and the contribution of insulin resistance to the pathogenesis of diabetic cardiomyopathy.Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction.Coffee consumption and risk of stroke in women.Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats.Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathwayBody adiposity dictates different mechanisms of increased coronary reactivity related to improved in vivo cardiac function.Ischemic preconditioning: Interruption of various disorders.Insulin says NO to cardiovascular disease.Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults.Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Genetic disruption of the cardiomyocyte circadian clock differentially influences insulin-mediated processes in the heart.Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes.Impact of estradiol on insulin signaling in the rat heart.APPL1 transgenic mice are protected from high-fat diet-induced cardiac dysfunction.Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future Directions.
P2860
Q26997062-70DDB356-D4DD-44BE-AAC0-0124E7931995Q28395852-9C9E9551-0CED-4280-8955-8F4E136F6FD7Q30945275-9649D51D-FD52-4119-B3D9-3DDAD42FD2DEQ33917887-B9057E33-FA47-4A7A-B7D9-706CB0E882C0Q33991754-817E3496-0AFE-44B3-A27E-F1079CAB732DQ34043589-A4A3F49B-D48B-4C56-93C9-6B7BB417A3DDQ34116118-BB009568-5697-41AD-B0B3-D89D8197DE0FQ35080377-ED7409FC-7094-4BA1-B756-43B20B196F5CQ35082986-C15CDCF3-5232-4922-BC4C-D7FD145B8573Q36381495-E83F0443-66BF-49B2-BC84-33EC66AE29CFQ36682368-D4D98CD6-D1A8-4FF8-9FA2-4D93065DFE8CQ36814087-F2AA3863-6FF2-4772-BF84-3A8EC62854CBQ36844816-DCE0BA39-9B86-405B-AF50-864A45177ABEQ37176185-08CBCFF2-4975-4AAB-8FA4-1D95C6ABCEE4Q37242310-5CC83BC6-1663-4F54-91AE-354C45B200EEQ37311992-56831F40-80E7-4529-8ED5-4AB2496DABCAQ37335886-04E54E3E-E538-4A72-989B-DD09FD012283Q37339937-6629BB6C-FC3E-4290-98F6-A18B6273F0DEQ37403315-133579AF-1D1B-4B20-A3B9-9E741758CF10Q37717293-61F8357D-ADB2-4329-90FD-967E11805EBCQ37721389-64F35D9F-0DBD-4BF8-A0EE-5485D50C45CAQ37807194-E23EE98E-4424-47E6-9629-FE59513427A0Q37913053-AE8DE9D9-53E3-41C1-AC5B-ADDF65702DE3Q37993133-F5F1CF14-2FBB-4E6C-86EA-3EC8B8C8B269Q38389314-DAE0E53F-7A1F-4F04-8779-779EBD33D2BFQ38665748-0E8720BB-F0A4-4D0D-9579-6EFC66352B45Q38712728-888DA2AD-1548-4F2A-A509-046F717E188CQ42449642-389BD837-45B2-40D0-8747-A4F0E17E8B97Q47845157-8090C5F7-91F4-4781-BE41-19F298EED643Q52673331-ADF56182-16A1-4E38-AE28-3E603D7F418A
P2860
Myocardial insulin resistance and cardiac complications of diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Myocardial insulin resistance and cardiac complications of diabetes.
@ast
Myocardial insulin resistance and cardiac complications of diabetes.
@en
type
label
Myocardial insulin resistance and cardiac complications of diabetes.
@ast
Myocardial insulin resistance and cardiac complications of diabetes.
@en
prefLabel
Myocardial insulin resistance and cardiac complications of diabetes.
@ast
Myocardial insulin resistance and cardiac complications of diabetes.
@en
P356
P1476
Myocardial insulin resistance and cardiac complications of diabetes
@en
P2093
E Dale Abel
P304
P356
10.2174/1568008054064869
P50
P577
2005-06-01T00:00:00Z